CoChat

Decreased Plasma Lipoprotein Lipase in Hypoadiponectinemia

von Eynatten, Maximilian, Schneider, Jochen G., Humpert, Per M., Rudofsky, Gottfried, Schmidt, Nikolaus, Barosch, Patrizia, Hamann, Andreas, Morcos, Michael, Kreuzer, Joerg, Bierhaus, Angelika, Nawroth, Peter P., Dugi, Klaus A. · 2004 · Diabetes Care
Cited by 138

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

OBJECTIVE—Adiponectin is a plasma protein expressed in adipose tissue. Hypoadiponectinemia is associated with low HDL cholesterol and high plasma triglycerides, which also characterize lipoprotein lipase (LPL) deficiency syndromes. Recently, dramatically increased LPL activity was reported in mice overexpressing adiponectin. We therefore speculated that adiponectin may directly affect LPL in humans. RESEARCH DESIGN AND METHODS—We measured plasma adiponectin and postheparin LPL in 206 nondiabetic men and in a second group of 110 patients with type 2 diabetes. Parameters were correlated with markers of systemic inflammation (C-reactive protein [CRP]) and insulin resistance (homeostatis model assessment of insulin resistance [HOMA-IR]). RESULTS—Nondiabetic subjects with decreased plasma adiponectin had lower LPL activity (r = 0.42, P < 0.0001). This association of plasma adiponectin with LPL activity was confirmed in the second group of patients with type 2 diabetes (r = 0.37, P < 0.0001). Multivariate analysis revealed that adiponectin was the strongest factor influencing LPL activity, accounting for 23% of the variation in LPL activity in nondiabetic subjects and for 26% of the variation in LPL activity in type 2 diabetic patients. These associations were independent of plasma CRP and HOMA-IR. CONCLUSIONS—These results demonstrate an association of decreased postheparin LPL activity with low plasma adiponectin that is independent of systemic inflammation and insulin resistance. Therefore, LPL may represent a link between low adiponectin levels and dyslipidemia in both nondiabetic individuals and patients with type 2 diabetes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/diacare.27.12.2925

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Cited by

See all 138

Metadata

Authors
von Eynatten, M., Schneider, J. G., Humpert, P. M., Rudofsky, G., Schmidt, N., Barosch, P., Hamann, A., Morcos, M., Kreuzer, J., Bierhaus, A., Nawroth, P. P., & Dugi, K. A.
Venue
Diabetes Care
Published
2004-12-01
Volume
27
Issue
12
Pages
2925-2929
ISSN
  • 0149-5992 (ISSN-L)
  • 1935-5548
OpenAlex
W2064469800
Cited by
138
References
7
FWCI
11.98
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Decreased Plasma Lipoprotein Lipase in Hypoadiponectinemia. https://app.cochat.ai/papers/10.2337/diacare.27.12.2925
The paper
von Eynatten, M., Schneider, J. G., Humpert, P. M., Rudofsky, G., Schmidt, N., Barosch, P., Hamann, A., Morcos, M., Kreuzer, J., Bierhaus, A., Nawroth, P. P., & Dugi, K. A. (2004). Decreased Plasma Lipoprotein Lipase in Hypoadiponectinemia. Diabetes Care. https://doi.org/10.2337/diacare.27.12.2925

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.